BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25789701)

  • 1. IL-31 Induces Chemotaxis, Calcium Mobilization, Release of Reactive Oxygen Species, and CCL26 in Eosinophils, Which Are Capable to Release IL-31.
    Kunsleben N; Rüdrich U; Gehring M; Novak N; Kapp A; Raap U
    J Invest Dermatol; 2015 Jul; 135(7):1908-1911. PubMed ID: 25789701
    [No Abstract]   [Full Text] [Related]  

  • 2. Eotaxin-3/CC chemokine ligand 26 is a functional ligand for CX3CR1.
    Nakayama T; Watanabe Y; Oiso N; Higuchi T; Shigeta A; Mizuguchi N; Katou F; Hashimoto K; Kawada A; Yoshie O
    J Immunol; 2010 Dec; 185(11):6472-9. PubMed ID: 20974991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of mRNA for eotaxin-2 and eotaxin-3 in human dermal fibroblasts and their distinct activation profile on human eosinophils.
    Dulkys Y; Schramm G; Kimmig D; Knöss S; Weyergraf A; Kapp A; Elsner J
    J Invest Dermatol; 2001 Apr; 116(4):498-505. PubMed ID: 11286614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemokine receptor CCR3 participates in tissue remodeling during atopic skin inflammation.
    Gaspar K; Kukova G; Bunemann E; Buhren BA; Sonkoly E; Szollosi AG; Muller A; Savinko T; Lauerma AI; Alenius H; Kemeny L; Dieu-Nosjean MC; Stander S; Fischer JW; Ruzicka T; Zlotnik A; Szegedi A; Homey B
    J Dermatol Sci; 2013 Jul; 71(1):12-21. PubMed ID: 23702389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-4 and interleukin-13 enhance CCL26 production in a human keratinocyte cell line, HaCaT cells.
    Kagami S; Saeki H; Komine M; Kakinuma T; Tsunemi Y; Nakamura K; Sasaki K; Asahina A; Tamaki K
    Clin Exp Immunol; 2005 Sep; 141(3):459-66. PubMed ID: 16045735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of human eosinophils and epidermal keratinocytes by Th2 cytokine IL-31: implication for the immunopathogenesis of atopic dermatitis.
    Cheung PF; Wong CK; Ho AW; Hu S; Chen DP; Lam CW
    Int Immunol; 2010 Jun; 22(6):453-67. PubMed ID: 20410259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophils and atopic dermatitis.
    Simon D; Braathen LR; Simon HU
    Allergy; 2004 Jun; 59(6):561-70. PubMed ID: 15147438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of atopic dermatitis.
    Kang K; Stevens SR
    Clin Dermatol; 2003; 21(2):116-21. PubMed ID: 12706329
    [No Abstract]   [Full Text] [Related]  

  • 9. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES).
    Ying S; Robinson DS; Meng Q; Barata LT; McEuen AR; Buckley MG; Walls AF; Askenase PW; Kay AB
    J Immunol; 1999 Oct; 163(7):3976-84. PubMed ID: 10491000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human eotaxin represents a potent activator of the respiratory burst of human eosinophils.
    Elsner J; Höchstetter R; Kimmig D; Kapp A
    Eur J Immunol; 1996 Aug; 26(8):1919-25. PubMed ID: 8765040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-4 regulates chemokine CCL26 in keratinocytes through the Jak1, 2/Stat6 signal transduction pathway: Implication for atopic dermatitis.
    Bao L; Shi VY; Chan LS
    Mol Immunol; 2012 Feb; 50(1-2):91-7. PubMed ID: 22226123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of Th2-associated chemokines in bullous pemphigoid disease. Role of eosinophils in the production and release of these chemokines.
    Gounni Abdelilah S; Wellemans V; Agouli M; Guenounou M; Hamid Q; Beck LA; Lamkhioued B
    Clin Immunol; 2006 Aug; 120(2):220-31. PubMed ID: 16782408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-derived neurotrophic factor is increased in atopic dermatitis and modulates eosinophil functions compared with that seen in nonatopic subjects.
    Raap U; Goltz C; Deneka N; Bruder M; Renz H; Kapp A; Wedi B
    J Allergy Clin Immunol; 2005 Jun; 115(6):1268-75. PubMed ID: 15940146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
    Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
    Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced CCL26 production by IL-4 through IFN-gamma-induced upregulation of type 1 IL-4 receptor in keratinocytes.
    Nishi N; Yamamoto S; Ou W; Muro E; Inada Y; Hamasaki Y
    Biochem Biophys Res Commun; 2008 Nov; 376(1):234-40. PubMed ID: 18774776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basophils regulate the recruitment of eosinophils in a murine model of irritant contact dermatitis.
    Nakashima C; Otsuka A; Kitoh A; Honda T; Egawa G; Nakajima S; Nakamizo S; Arita M; Kubo M; Miyachi Y; Kabashima K
    J Allergy Clin Immunol; 2014 Jul; 134(1):100-7. PubMed ID: 24713170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLAG (1-Palmitoyl-2-Linoleoyl-3-Acetyl-rac-Glycerol) Modulates Eosinophil Chemotaxis by Regulating CCL26 Expression from Epithelial Cells.
    Jeong J; Kim YJ; Yoon SY; Kim YJ; Kim JH; Sohn KY; Kim HJ; Han YH; Chong S; Kim JW
    PLoS One; 2016; 11(3):e0151758. PubMed ID: 27010397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines.
    Stellato C; Collins P; Ponath PD; Soler D; Newman W; La Rosa G; Li H; White J; Schwiebert LM; Bickel C; Liu M; Bochner BS; Williams T; Schleimer RP
    J Clin Invest; 1997 Mar; 99(5):926-36. PubMed ID: 9062350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TP receptor-mediated release of eosinophil chemotactic activity from human bronchial smooth muscle cells.
    Suzuki Y; Asano K; Niimi K; Miyata J; Shiraishi Y; Fukunaga K; Shiomi T; Nakajima T; Oguma T; Sayama K; Ishizaka A
    Eur J Pharmacol; 2008 Dec; 600(1-3):133-9. PubMed ID: 18950617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of P2Y and P2X receptors in human eosinophils.
    Idzko M; Dichmann S; Panther E; Ferrari D; Herouy Y; Virchow C; Luttmann W; Di Virgilio F; Norgauer J
    J Cell Physiol; 2001 Sep; 188(3):329-36. PubMed ID: 11473359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.